DNA repair pathways as targets for cancer therapy.

DNA repair pathways can enable tumour cells to survive DNA damage that is induced by chemotherapeutic treatments; therefore, inhibitors of specific DNA repair pathways might prove efficacious when used in combination with DNA-damaging chemotherapeutic drugs. In addition, alterations in DNA repair pa...

Full description

Bibliographic Details
Main Authors: Helleday, T, Petermann, E, Lundin, C, Hodgson, B, Sharma, R
Format: Journal article
Language:English
Published: 2008
_version_ 1826271456334446592
author Helleday, T
Petermann, E
Lundin, C
Hodgson, B
Sharma, R
author_facet Helleday, T
Petermann, E
Lundin, C
Hodgson, B
Sharma, R
author_sort Helleday, T
collection OXFORD
description DNA repair pathways can enable tumour cells to survive DNA damage that is induced by chemotherapeutic treatments; therefore, inhibitors of specific DNA repair pathways might prove efficacious when used in combination with DNA-damaging chemotherapeutic drugs. In addition, alterations in DNA repair pathways that arise during tumour development can make some cancer cells reliant on a reduced set of DNA repair pathways for survival. There is evidence that drugs that inhibit one of these pathways in such tumours could prove useful as single-agent therapies, with the potential advantage that this approach could be selective for tumour cells and have fewer side effects.
first_indexed 2024-03-06T21:56:56Z
format Journal article
id oxford-uuid:4d3ab431-934b-41e8-b5d9-9bffaaf3245b
institution University of Oxford
language English
last_indexed 2024-03-06T21:56:56Z
publishDate 2008
record_format dspace
spelling oxford-uuid:4d3ab431-934b-41e8-b5d9-9bffaaf3245b2022-03-26T15:54:18ZDNA repair pathways as targets for cancer therapy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4d3ab431-934b-41e8-b5d9-9bffaaf3245bEnglishSymplectic Elements at Oxford2008Helleday, TPetermann, ELundin, CHodgson, BSharma, RDNA repair pathways can enable tumour cells to survive DNA damage that is induced by chemotherapeutic treatments; therefore, inhibitors of specific DNA repair pathways might prove efficacious when used in combination with DNA-damaging chemotherapeutic drugs. In addition, alterations in DNA repair pathways that arise during tumour development can make some cancer cells reliant on a reduced set of DNA repair pathways for survival. There is evidence that drugs that inhibit one of these pathways in such tumours could prove useful as single-agent therapies, with the potential advantage that this approach could be selective for tumour cells and have fewer side effects.
spellingShingle Helleday, T
Petermann, E
Lundin, C
Hodgson, B
Sharma, R
DNA repair pathways as targets for cancer therapy.
title DNA repair pathways as targets for cancer therapy.
title_full DNA repair pathways as targets for cancer therapy.
title_fullStr DNA repair pathways as targets for cancer therapy.
title_full_unstemmed DNA repair pathways as targets for cancer therapy.
title_short DNA repair pathways as targets for cancer therapy.
title_sort dna repair pathways as targets for cancer therapy
work_keys_str_mv AT helledayt dnarepairpathwaysastargetsforcancertherapy
AT petermanne dnarepairpathwaysastargetsforcancertherapy
AT lundinc dnarepairpathwaysastargetsforcancertherapy
AT hodgsonb dnarepairpathwaysastargetsforcancertherapy
AT sharmar dnarepairpathwaysastargetsforcancertherapy